CVS Health Corp. stock rallies 3.34% to $80.98, outperforming market

9 articles · Updated · MarketWatch · Apr 28

CVS shares gained for a second straight day, closing at $80.98, with trading volume reaching 8.3 million, above its 50-day average.
The stock outperformed the S&P 500 and Dow Jones, both of which declined, and fared better than Amazon, while UnitedHealth and Elevance Health also posted gains.
CVS remains 4.90% below its 52-week high of $85.15 set in October, reflecting resilience amid a broader market downturn.

Why did CVS stock surge despite the company's cautious 2026 profit outlook?

What will the May 6th earnings call reveal about CVS's future under regulatory pressure?

Following its Rite Aid deal, is CVS expanding healthcare access or just crushing competition?

Can CVS's business model survive the government's crackdown on pharmacy benefit managers?

With new laws reshaping Medicare, how will CVS's Aetna insurance arm adapt?

Will the FTC settlement on insulin costs actually lower prices for patients?